| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |